Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 USD | -5.77% | +5.00% | -85.02% |
Financials (USD)
Sales 2024 * | 193M | Sales 2025 * | 285M | Capitalization | 425M |
---|---|---|---|---|---|
Net income 2024 * | -283M | Net income 2025 * | -235M | EV / Sales 2024 * | 4.44 x |
Net Debt 2024 * | 432M | Net Debt 2025 * | 502M | EV / Sales 2025 * | 3.25 x |
P/E ratio 2024 * |
-1.5
x | P/E ratio 2025 * |
-1.85
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.18% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | -5.77% | ||
1 week | +5.00% | ||
Current month | -60.80% | ||
1 month | -59.28% | ||
3 months | -79.09% | ||
6 months | -79.75% | ||
Current year | -85.02% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.47 | -5.77% | 9,818,090 |
24-04-22 | 1.56 | +0.65% | 8,964,453 |
24-04-19 | 1.55 | +6.16% | 16,879,745 |
24-04-18 | 1.46 | +4.29% | 18,742,356 |
24-04-17 | 1.4 | 0.00% | 35,377,652 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.02% | 425M | |
+8.35% | 209B | |
+9.41% | 175B | |
+11.75% | 131B | |
+19.34% | 99.98B | |
-0.84% | 61.12B | |
+15.08% | 52.34B | |
-2.10% | 46.5B | |
+0.10% | 39.24B | |
+11.50% | 38.47B |
- Stock Market
- Equities
- PACB Stock